Omnicare (OCR) 10% Higher After ValueAct's Ubben Joins Board

Shares of Omnicare, Inc. (NYSE: OCR) are 10% higher today after the company named Jeffrey W. Ubben, chief investment officer and a founder of ValueAct Capital, to its Board of Directors.

ValueAct Capital has entered into a standstill agreement with the Company.

ValueAct Capital currently owns approximately 9.68% of the Company's outstanding shares.

You May Also Be Interested In

• OpenAI and Synopsys partner to develop chip design AI model
• CJ 4DPLEX and Cinemark to add 20 ScreenX locations in the Americas
• WiMi develops quantum computing simulation model with hybrid architecture